These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions. Goel T; Garg S Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015 [TBL] [Abstract][Full Text] [Related]
44. [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance]. Wang L; Chen ZJ; Wang QT; Cao WF; Jian Y; Wang SX; Zhang BH Zhonghua Nan Ke Xue; 2006 Jan; 12(1):57-9. PubMed ID: 16483162 [TBL] [Abstract][Full Text] [Related]
45. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Mohler JL; Chen Y; Hamil K; Hall SH; Cidlowski JA; Wilson EM; French FS; Sar M Clin Cancer Res; 1996 May; 2(5):889-95. PubMed ID: 9816246 [TBL] [Abstract][Full Text] [Related]
46. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer. Tang J; Wang Z; Li X; Li J; Shi H Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586 [TBL] [Abstract][Full Text] [Related]
47. [BRG1 expression in prostate carcinoma by application of tissue microarray]. Li Y; Shi QL; Jin XZ; Meng K; Zhou XJ; Sun LP Zhonghua Nan Ke Xue; 2006 Jul; 12(7):629-32. PubMed ID: 16894943 [TBL] [Abstract][Full Text] [Related]
48. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues]. Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871 [TBL] [Abstract][Full Text] [Related]
49. Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). Giannulis I; Montironi R; Galluzzi CM; de Nictolis M; Diamanti L Anticancer Res; 1993; 13(6B):2447-51. PubMed ID: 7510939 [TBL] [Abstract][Full Text] [Related]
50. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer. Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472 [TBL] [Abstract][Full Text] [Related]
51. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis. Cardillo MR; Ippoliti F Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460 [TBL] [Abstract][Full Text] [Related]
52. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features. Gabal SM; Habib FM; Helmy DO; Ibrahim MF J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287 [TBL] [Abstract][Full Text] [Related]
53. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Helpap B Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872 [TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies. Stewart J; Fleshner N; Cole H; Toi A; Sweet J J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427 [TBL] [Abstract][Full Text] [Related]
55. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma. Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298 [TBL] [Abstract][Full Text] [Related]
56. Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy. Miličević N; Mrčela M; Galić J; Marjanović K Pathol Res Pract; 2015 Nov; 211(11):865-70. PubMed ID: 26376467 [TBL] [Abstract][Full Text] [Related]
57. Over-diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 cases. Bostwick DG; Ma J BJU Int; 2007 Nov; 100(5):1036-9. PubMed ID: 17922786 [TBL] [Abstract][Full Text] [Related]
58. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study. Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561 [TBL] [Abstract][Full Text] [Related]
59. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8. Dorkin TJ; Robinson MC; Marsh C; Neal DE; Leung HY J Pathol; 1999 Dec; 189(4):564-9. PubMed ID: 10629559 [TBL] [Abstract][Full Text] [Related]
60. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation. Wang W; Bergh A; Damber JE APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]